Black Rock Inc. Vyant Bio, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.62 - $1.37 $47,812 - $105,650	-77,117 Reduced 36.74%	132,797 $121,000
Q1 2022 May 12, 2022	SELL	$0.99 - $1.61 $3,715 - $6,042	-3,753 Reduced 1.76%	209,914 $301,000
Q4 2021 Feb 10, 2022	BUY	$1.32 - $2.96 $4,233 - $9,492	3,207 Added 1.52%	213,667 $288,000
Q3 2021 Nov 09, 2021	SELL	$2.26 - $3.74 $3,769 - $6,238	-1,668 Reduced 0.79%	210,460 $490,000
Q2 2021 Aug 11, 2021	BUY	$2.88 - $4.81 $610,928 - $1.02 Million	212,128 New	212,128 $794,000

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.